🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Up at BATS today, we have... Lauren Duhamel (Wittrup Lab) Engineering Strategies to Modulate CD45 Signaling for Cancer Immunotherapy Kwan Yoon (Christopher Voigt) Engineering Bidirectional Plant-microbe Signaling to Combat Plant Disease be.mit.edu/news-events/ba…

Huge congrats to Dr. Anthony Tabet on a phenomenal PhD defense today. Anthony was co-advised by the Bioelectronics @ MIT and leveraged the unique skill sets of both labs to push the boundaries of cancer neuroimmunology. Excited to see what you accomplish next!

Excited to share my first first author paper and a large part of my PhD work. A quick tweetorial 🧵 (1/13) biorxiv.org/content/10.110…

Check out our latest work on the role Tregs play in limiting responses to local anti-4-1BB therapy. Also if you’re looking to hire post docs to study T cell biology/dysfunction Joseph is graduating soon and looking for positions!!

SPOTLIGHT: To enhance the effectiveness and safety of stimulatory receptor agonist antibodies, researchers at MIT Dept of BE developed a collagen-targeting 4-1BB agonist Ab and delivered it directly into B16 melanoma tumors along [...] ow.ly/EjR650N622g

Join Koch Institute immune engineers and Ankyra Therapeutics CEO Howard Kaufman on April 4 to hear how they are taking anchored immunotherapy against solid tumors from the lab bench to the cancer clinic. Register: bit.ly/Apr2023-wis

Successfully defended my PhD in chemical engineering from Massachusetts Institute of Technology (MIT) last week. Wouldn’t have made it through this journey without the endless support of my colleagues in Wittrup Lab and all of my friends and family. Excited for the next adventure!

"I think that back and forth between the industry and the clinical settings and open communication helps to find the next boundary that we can push." Watch the video of our latest with/in/sight, "Anchor Management." youtu.be/lJmLu7lB8zM

SPOTLIGHT: To improve the therapeutic window of IL-2 and IL-12, Massachusetts Institute of Technology (MIT) evaluated canine-ized collagen-binding IL-2 and IL-12 in pet beagles with spontaneous soft tissue sarcomas 👉 bit.ly/3mDubkX

acir.org/weekly-digests…

In other news, I’m back in NH today with my Wittrup Lab friends to run a Ragnar road race. Follow along as we run a 200 mile relay over the next 30 hours 😤😤😤

Excited to share that the second paper from my post-doc is out! This was a very fun 4-way collaboration between the Stefani Spranger, White, and Wittrup Lab labs at Massachusetts Institute of Technology (MIT) and the Garcia lab at Stanford University! Koch Institute at MIT MIT Biology SITC Early Career Scientist Committee insight.jci.org/articles/view/…

Curious what we’ve been up to recently? Check out our posters at #SITC23 today to learn about collagen anchored cytokine therapy in canines (1094) and how Tregs constrain responses to collagen anchored anti-4-1BB agonist antibody therapy (1224)!

linkedin.com/posts/karl-dan…

Kicking off 2024 by sharing a preprint of my PhD work! We report an engineered cytokine therapy that elicits some of the most profound anti-tumor immunity we have seen in our labs' preclinical work. Preprint and walk-through below:

.Wittrup Lab reported the development of a tumor-anchored ɑ4-1BB agonist, which consists of a ɑ4-1BB antibody fused to the collagen-binding protein leukocyte associated immunoglobulin like receptor. Koch Institute at MIT 🔗 go.nature.com/3UZDvhT

Palmeri et al. fused an agonistic anti-4-1BB Ab and the collagen-binding domain of LAIR1 (ɑ4-1BB-LAIR). However, treating mouse tumor models with ɑ4-1BB-LAIR i.t. plus an Ab specific for tumor-expressed antigen [...] bit.ly/4ackehO  Joseph Palmeri  @theWittrupLab

A bit late sharing but excited to see my PhD work out in Nature Communications! Huge shoutout to all of my coauthors and my PhD advisor for helping get this across the finish line. Not much has changed since the preprint so I’ll link to that tweetorial below nature.com/articles/s4146…

How AI Revolutionized Protein Science, but Didn’t End It 3 years ago, Google’s AlphaFold pulled off the biggest artificial intelligence breakthrough in science to date, accelerating molecular research and kindling deep questions about why we do science. quantamagazine.org/how-ai-revolut…